In dieser Studie wurden spezifische IgM- und IgG-AntikÖrper (Elisa) gegen Herpes-simplex-Typ-1-Viren (HSV-1) bei 62 Patienten mit idiopathischer Fazialisparese, bei 20 Patienten mit Herpes labialis und bei gesunden Kontrollpersonen bestimmt. Ausserdem wurde versucht, HSV-1-Genom mittels der Polymerasekettenreaktion (PKR) zum einen bei Autopsien im humanen Ganglion geniculi und zum anderen in Serum von Patienten mit idiopathischer Fazialisparese nachzuweisen. Die Ergebnisse dieser Studie zeigen 1. nahezu identische AntikÒrpertiter bein Herpes labialis (einer gesicherten Reaktivierung von HSV-1) und bei der idiopathischen Fazialisparese (einer vermuteten Reaktivierung von HSV-1) sowie 2. HSV-1-Genom im menschlichen Ganglion geniculi. Diese Befunde sprechen fur die Hypothese, dass in der Mehrzahl der FÄlle die Reaktivierung von HSV-1 die Ursache der idiopathischen Fazialisparese ist.

Keywords:
Idiopathische Fazialisparese, Herpes-simplex-Typ-1 – Viren, Polymerasekettenreaktion, Antikörpertiter
This content is only available via PDF.
© 1994 S. Karger AG, Basel
1994
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.